TY - JOUR
T1 - Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in the Elderly
AU - Wong, Lye Yeng
AU - Alver, Naima
AU - Dewey, Elizabeth N.
AU - Bhamidipati, Castigliano
AU - Lantz, Gurion
AU - Tibayan, Frederick A.
AU - Heitner, Stephen
AU - Masri, Ahmad
AU - Song, Howard K.
N1 - Publisher Copyright:
© 2022 The Society of Thoracic Surgeons
PY - 2022/5
Y1 - 2022/5
N2 - Background: Hypertrophic obstructive cardiomyopathy is a genetic disorder treated with septal reduction therapy, either alcohol septal ablation or septal myectomy (SM). Historically older patients have been presumed to be poor candidates for SM and thus referred directly for alcohol septal ablation in some centers. We reviewed our experience with SM in older patients. Methods: We identified 100 patients at our institution who underwent SM for hypertrophic obstructive cardiomyopathy from 2015 to 2020. Demographic and clinical characteristics and outcomes of patients 65 years or older were compared with patients younger than 65. Results: Sixty-five patients were in the <65 group and 35 patients in the ≥65 group. Both groups had similar preoperative peak stress left ventricular outflow tract gradients (129 mm Hg vs 110 mm Hg, P < .001). Most patients in both groups had moderate to severe mitral regurgitation on preoperative stress echocardiography. The elderly group was more likely to have coronary artery bypass graft as a concomitant procedure (37% vs 8%, P < .001). Only 1 death occurred in the series secondary to a pulmonary embolism. At the 30-day follow-up on stress echocardiography, peak stress gradients were normal in both groups (21 and 20 mm Hg, respectively; P < .001), and 88% of all patients had trace to mild mitral regurgitation. Conclusions: Properly selected older patients can safely undergo SM with excellent outcomes similar to younger patients. Relief of left ventricular outflow tract obstruction and correction of mitral regurgitation are reliably achieved in both groups. Advanced age should not be a strict criteria for selecting septal reduction therapy approach.
AB - Background: Hypertrophic obstructive cardiomyopathy is a genetic disorder treated with septal reduction therapy, either alcohol septal ablation or septal myectomy (SM). Historically older patients have been presumed to be poor candidates for SM and thus referred directly for alcohol septal ablation in some centers. We reviewed our experience with SM in older patients. Methods: We identified 100 patients at our institution who underwent SM for hypertrophic obstructive cardiomyopathy from 2015 to 2020. Demographic and clinical characteristics and outcomes of patients 65 years or older were compared with patients younger than 65. Results: Sixty-five patients were in the <65 group and 35 patients in the ≥65 group. Both groups had similar preoperative peak stress left ventricular outflow tract gradients (129 mm Hg vs 110 mm Hg, P < .001). Most patients in both groups had moderate to severe mitral regurgitation on preoperative stress echocardiography. The elderly group was more likely to have coronary artery bypass graft as a concomitant procedure (37% vs 8%, P < .001). Only 1 death occurred in the series secondary to a pulmonary embolism. At the 30-day follow-up on stress echocardiography, peak stress gradients were normal in both groups (21 and 20 mm Hg, respectively; P < .001), and 88% of all patients had trace to mild mitral regurgitation. Conclusions: Properly selected older patients can safely undergo SM with excellent outcomes similar to younger patients. Relief of left ventricular outflow tract obstruction and correction of mitral regurgitation are reliably achieved in both groups. Advanced age should not be a strict criteria for selecting septal reduction therapy approach.
UR - http://www.scopus.com/inward/record.url?scp=85119279902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119279902&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2021.05.058
DO - 10.1016/j.athoracsur.2021.05.058
M3 - Article
C2 - 34139186
AN - SCOPUS:85119279902
SN - 0003-4975
VL - 113
SP - 1477
EP - 1481
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 5
ER -